866-997-4948(US-Canada Toll Free)

United States Golimumab Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 97 Pages

Notes:
Sales, means the sales volume of Golimumab
Revenue, means the sales value of Golimumab

This report studies sales (consumption) of Golimumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
GlaxoSmithKline
Sandoz
Celltrion
Janssen Biotech
Bionovis
Reliance Life Sciences
AryoGen Biopharma
Simcere Pharmaceutical
Samsung Bioepis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Golimumab in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

United States Golimumab Market Report 2016
1 Golimumab Overview
1.1 Product Overview and Scope of Golimumab
1.2 Classification of Golimumab
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Golimumab
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Golimumab (2011-2021)
1.4.1 United States Golimumab Sales and Growth Rate (2011-2021)
1.4.2 United States Golimumab Revenue and Growth Rate (2011-2021)

2 United States Golimumab Competition by Manufacturers
2.1 United States Golimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Golimumab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Golimumab Average Price by Manufactures (2015 and 2016)
2.4 Golimumab Market Competitive Situation and Trends
2.4.1 Golimumab Market Concentration Rate
2.4.2 Golimumab Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Golimumab Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Golimumab Sales and Market Share by Type (2011-2016)
3.2 United States Golimumab Revenue and Market Share by Type (2011-2016)
3.3 United States Golimumab Price by Type (2011-2016)
3.4 United States Golimumab Sales Growth Rate by Type (2011-2016)

4 United States Golimumab Sales (Volume) by Application (2011-2016)
4.1 United States Golimumab Sales and Market Share by Application (2011-2016)
4.2 United States Golimumab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Golimumab Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Golimumab Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
5.2.2 Golimumab Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 GlaxoSmithKline Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Sandoz
5.3.2 Golimumab Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Sandoz Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Celltrion
5.4.2 Golimumab Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Celltrion Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Janssen Biotech
5.5.2 Golimumab Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Janssen Biotech Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Bionovis
5.6.2 Golimumab Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Bionovis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Reliance Life Sciences
5.7.2 Golimumab Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Reliance Life Sciences Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 AryoGen Biopharma
5.8.2 Golimumab Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 AryoGen Biopharma Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Simcere Pharmaceutical
5.9.2 Golimumab Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Simcere Pharmaceutical Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Samsung Bioepis
5.10.2 Golimumab Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Samsung Bioepis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview

6 Golimumab Manufacturing Cost Analysis
6.1 Golimumab Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Golimumab

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Golimumab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Golimumab Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Golimumab Market Forecast (2016-2021)
10.1 United States Golimumab Sales, Revenue Forecast (2016-2021)
10.2 United States Golimumab Sales Forecast by Type (2016-2021)
10.3 United States Golimumab Sales Forecast by Application (2016-2021)
10.4 Golimumab Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Golimumab
Table Classification of Golimumab
Figure United States Sales Market Share of Golimumab by Type in 2015
Table Application of Golimumab
Figure United States Sales Market Share of Golimumab by Application in 2015
Figure United States Golimumab Sales and Growth Rate (2011-2021)
Figure United States Golimumab Revenue and Growth Rate (2011-2021)
Table United States Golimumab Sales of Key Manufacturers (2015 and 2016)
Table United States Golimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Golimumab Sales Share by Manufacturers
Figure 2016 Golimumab Sales Share by Manufacturers
Table United States Golimumab Revenue by Manufacturers (2015 and 2016)
Table United States Golimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Golimumab Revenue Share by Manufacturers
Table 2016 United States Golimumab Revenue Share by Manufacturers
Table United States Market Golimumab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Golimumab Average Price of Key Manufacturers in 2015
Figure Golimumab Market Share of Top 3 Manufacturers
Figure Golimumab Market Share of Top 5 Manufacturers
Table United States Golimumab Sales by Type (2011-2016)
Table United States Golimumab Sales Share by Type (2011-2016)
Figure United States Golimumab Sales Market Share by Type in 2015
Table United States Golimumab Revenue and Market Share by Type (2011-2016)
Table United States Golimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Golimumab by Type (2011-2016)
Table United States Golimumab Price by Type (2011-2016)
Figure United States Golimumab Sales Growth Rate by Type (2011-2016)
Table United States Golimumab Sales by Application (2011-2016)
Table United States Golimumab Sales Market Share by Application (2011-2016)
Figure United States Golimumab Sales Market Share by Application in 2015
Table United States Golimumab Sales Growth Rate by Application (2011-2016)
Figure United States Golimumab Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Golimumab Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Golimumab Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Golimumab Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Golimumab Sales Market Share (2011-2016)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech Golimumab Sales Market Share (2011-2016)
Table Bionovis Basic Information List
Table Bionovis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionovis Golimumab Sales Market Share (2011-2016)
Table Reliance Life Sciences Basic Information List
Table Reliance Life Sciences Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reliance Life Sciences Golimumab Sales Market Share (2011-2016)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table AryoGen Biopharma Golimumab Sales Market Share (2011-2016)
Table Simcere Pharmaceutical Basic Information List
Table Simcere Pharmaceutical Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Simcere Pharmaceutical Golimumab Sales Market Share (2011-2016)
Table Samsung Bioepis Basic Information List
Table Samsung Bioepis Golimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Bioepis Golimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Golimumab
Figure Manufacturing Process Analysis of Golimumab
Figure Golimumab Industrial Chain Analysis
Table Raw Materials Sources of Golimumab Major Manufacturers in 2015
Table Major Buyers of Golimumab
Table Distributors/Traders List
Figure United States Golimumab Production and Growth Rate Forecast (2016-2021)
Figure United States Golimumab Revenue and Growth Rate Forecast (2016-2021)
Table United States Golimumab Production Forecast by Type (2016-2021)
Table United States Golimumab Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *